ITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only

Similar documents
Larsen & Toubro Ltd.

Apollo Hospitals Enterprise Ltd.

Maruti Suzuki India Ltd.

JK Tyre & Industries Ltd.

Maruti Suzuki India Ltd.

Maruti Suzuki India Ltd.

Hindustan Unilever Ltd.

NTPC Ltd. BUY CMP (Rs.) 163 Target (Rs.) 188 Potential Upside 15% For private circulation only. Volume No.. II Issue No. 164.

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

ACC Ltd. BUY CMP (Rs.) 1,471 Target (Rs.) 1,655 Potential Upside 13% For private circulation only. Volume No.. II Issue No. 172.

J.B. Chemicals & Pharmaceuticals Ltd.

State Bank of India (SBI)

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Reliance Industries Ltd.

Aurobindo Pharma Ltd.

Bank of Baroda (BOB)

Tata Motors. BUY CMP (Rs.) 421 Target (Rs.) 480 Potential Upside 14% Strong show at both domestic & JLR businesses. Investment Rationale

PI Industries. BUY CMP (Rs.) 835 Target (Rs.) 937 Potential Upside 12% For private circulation only. Volume No.. I Issue No. 127.

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Eicher Motors Ltd. BUY CMP (Rs.) 30,680 Target (Rs.) 35,512 Potential Upside 16% For private circulation only. Volume No.. I Issue No.

Essel Propack Ltd. BUY CMP (Rs.) 295 Target (Rs.) 331 Potential Upside 12% Non-oral care category-bigger growth opportunity. Investment Rationale

Century Plyboards India Ltd.

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Persistent Systems Ltd

Steel Authority of India Ltd Steel Products HOLD RETAIL EQUITY RESEARCH. CMP Rs. 62 TARGET Rs. 65 RETURN 6% 24 th October 2017 COMPANY UPDATE

Indian Oil Corporation Ltd.

BUY CMP (Rs.) 315 Target (Rs.) 345 Potential Upside 10%

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Maruti Suzuki India Ltd. Auto BUY RETAIL EQUITY RESEARCH. 21 st November 2018 Q2FY19 RESULT UPDATE. CMP Rs. 7,332 TARGET Rs.

Buy Rating as per Mid Cap 12months investment period

BUY. NTPC Ltd Power RETAIL EQUITY RESEARCH

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

HOLD Rating as per Large Cap 12 month investment period

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

Maruti Suzuki India Ltd Automobiles BUY RETAIL EQUITY RESEARCH. On a strong footing. GEOJIT Research. 27 th Jan, 2017 Q3FY17 RESULT UPDATE

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY. JK Tyre & Industries Ltd Auto Ancillary RETAIL EQUITY RESEARCH

Arvind Ltd Textiles HOLD RETAIL EQUITY RESEARCH. CMP Rs. 413 TARGET Rs. 414 RETURN 0.1% 13 th September 2017 Q1FY18 RESULT UPDATE

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

BUY Rating as per Largecap 12months investment period

Berger Paints India Ltd Paints SELL RETAIL EQUITY RESEARCH. 27 th August 2018 Q1FY19 RESULT UPDATE. CMP Rs. 336 TARGET Rs.

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

Jagran Prakashan Ltd.

Ultratech Cement Ltd CEMENT BUY RETAIL EQUITY RESEARCH. 27 th July, 2017 Q1FY18 UPDATE. CMP Rs. 4,044 TARGET Rs. 4,514 RETURN 12%

Amber Enterprises India Ltd

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Voltas Ltd Capital Goods HOLD RETAIL EQUITY RESEARCH. 28 th February 2018 Q3FY18 RESULT UPDATE. CMP Rs. 607 TARGET Rs.

HOLD. Cipla Ltd Pharmaceuticals RETAIL EQUITY RESEARCH

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

State Bank of India (SBI) Banking BUY RETAIL EQUITY RESEARCH

HOLD Rating as per Large Cap 12 months investment period

HOLD. Hindustan Unilever Limited FMCG RETAIL EQUITY RESEARCH. 2 nd August 2018 Q1FY19 RESULT UPDATE. CMP Rs. 1,733 TARGET Rs.

ITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY

GSK Consumer Healthcare Ltd

Infosys Ltd IT HOLD RETAIL EQUITY RESEARCH. 23 rd January 2019 Q3FY19 RESULT UPDATE. CMP Rs. 744 TARGET Rs. 802 RETURN 8%

Religare Investment Call

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

ITC. Q1FY17 Result Update Healthy Operational Performance; Maintain BUY. Sector: FMCG CMP: ` 251. Recommendation: BUY

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Religare Investment Call

Procter & Gamble Hygiene & Health Care

HCL Technologies Ltd.

ITC Ltd. RESULT UPDATE 27th October, 2017

Grasim Industries Ltd CEMENT BUY RETAIL EQUITY RESEARCH. 29 th May, 2017 Q4FY17 UPDATE. CMP Rs1109 TARGET Rs1222 RETURN 10%

Hexaware Technologies Ltd IT SELL RETAIL EQUITY RESEARCH. 21 st September 2018 Q2CY18 RESULT UPDATE. CMP Rs. 447 TARGET Rs.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

JK Tyre & Industries Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Cig volumes surprise. Source: Company Data; PL Research

BUY. Tata Motors Ltd Auto RETAIL EQUITY RESEARCH

Religare Investment Call

Kajaria Ceramics Ltd.

Healty cigarette-driven growth

Fineotex Chemical Ltd

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Endurance Technologies Ltd Auto Ancillary HOLD RETAIL EQUITY RESEARCH. 5 th January 2018 COMPANY UPDATE. CMP Rs. 1,350 TARGET Rs. 1,354 RETURN 0.

HOLD. Dish TV India Ltd TV Distribution RETAIL EQUITY RESEARCH

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

Mahindra & Mahindra Ltd.

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

HOLD. Sun Pharmaceutical Industries Ltd. Pharmaceuticals RETAIL EQUITY RESEARCH. CMP Rs. 571 TARGET Rs. 597 RETURN 5% 19 th June, 2018 COMPANY UPDATE

Mahindra & Mahindra Ltd.

SELL Rating as per Largecap 12months investment period

V-GUARD INDUSTRIES LTD Electrical Equipments. Accumulate RETAIL EQUITY RESEARCH

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Colgate-Palmolive (India)

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Religare Investment Call

Vinati Organics Ltd Speciality Chemicals. Reduce RETAIL EQUITY RESEARCH

Transcription:

Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg Code: ITC:IN ITC is a diversified conglomerate, present across categories Cigarettes, Other FMCG, Hotels, Paper & Agri-business. ITC is a market leader in the cigarettes category with volume market share of ~75%. Investment Rationale Decent growth in topline Net sales grew by 7.6% YoY in Q1FY19 led by 14% YoY growth in FMCG (like-tolike basis), 12% YoY in hotels and modest 2.2% (our calculation) in cigarettes. Cigarette volumes surprised positively with growth of 1% YoY (our estimate) after 3 consecutive quarters of steep decline (-6% to -3%). FMCG segment also grew by impressive 14.3% YoY (like-to-like basis) with strong performance across Branded Packaged foods and personal care products. The company improved its market standing across segments driven by new product launches. Hotels segment also posted healthy growth in topline led by higher room rates and strong food and beverage sales. Agribusiness reported 14.2% YoY growth while Paperboards and Packaging segment witnessed muted performance (flat revenue) during the quarter as demand remained weak from end user industries. Recovery in cigarette volumes and better profitability in FMCG segment to aid margin growth EBITDA margin expanded by 161 bps YoY to 39.2% led by improved profitability in cigarettes, FMCG, hotels and paperboard segments. However, Agribusiness reported tepid performance due to pressure on legal cigarette industry volumes leading to adverse mix and lower export incentives. Further, PAT growth was restricted to 10.1% YoY in Q1FY19 due to lower other income. With recovery in cigarette volumes coupled with better profitability in FMCG segment, we expect EBITDA margin to expand to 38.9%/39.9% in FY19E/20E. Performance to only get better In Q1FY19 the company reported healthy performance across segments. Going ahead, we expect volume recovery to sustain in cigarettes and strong performance in FMCG segment to continue and as a result, factor revenue CAGR of 8.2%/14.2%, respectively over FY18-20E. This will drive overall revenue CAGR of 9.6% over FY18-20E. Market Data Rating One year Price Chart 350 300 250 200 ITC Sensex (Rebased) BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Duration Long Term Face Value (Rs.) 1.0 52 week H/L (Rs.) 323/250 Decline from 52WH (%) 7.1 Rise from 52WL (%) 20.0 Beta 1.2 Mkt. Cap (Rs.Cr) 370,800 Fiscal Year Ended Y/E FY17 FY18 FY19E FY20E Revenue (Rs.Cr) Adj. Net profit (Rs.Cr) 40,089 40,628 44,193 48,806 10,201 10,810 11,908 13,449 EPS (Rs.) 8.4 8.9 9.8 11.0 P/E (x) 36.2 34.3 31.1 27.6 P/BV (x) 8.1 7.2 6.7 6.3 ROE (%) 23.5 22.3 22.4 23.6 Valuation: Given ITC s leadership position in cigarette category, continued investment in FMCG business and favourable risk reward, we recommend BUY rating on the stock with a target price of Rs. 336 based on 30.5x FY20E EPS. Shareholding Pattern Jun-18 Mar-18 Chg. Promoters (%) 0.0 0.0 - FII (%) 17.5 18.0 (0.5) DII (%) 37.6 37.1 0.5 Public (%) 9.8 9.8 - Other (%) 35.1 35.1 -

ITC Ltd: Business Overview ITC is a diversified conglomerate, present across categories Cigarettes, Other FMCG, Hotels, Paper & Agri-business. ITC is a market leader in the cigarettes category with volume market share of ~75%. The company s consistent focus on research & development and brand building has resulted in creating aashirvaad the no. 1 in branded atta, bingo! the no. 1 in bridges segment of snack foods (no.2 overall), sunfeast the no. 1 in the premium cream biscuits segment, classmate the no. 1 in notebooks, yippee! the no. 2 in noodles, engage the no. 2 in deodorants (no. 1 in women s segment) and mangaldeep the no. 2 in agarbattis (no. 1 in dhoop segment). Paperboards, Paper and Packaging, 12% ITC s revenue mix Agri Business, 18% FMCG - Cigarettes, 43% Hotels, 3% FMCG - Others, 100% 25% Source: Company, In-house research Quarterly Financials (Standalone) YoY Growth % QoQ Growth % (Rs cr) Q1FY19 Q1FY18 Q4FY18 Sales 10,707 9,955 7.6 10,587 1.1 EBITDA 4,202 3,746 12.2 4,144 1.4 Margin (%) 39.2 37.6 161bps 39.1 10bps Depreciation 299 268 11.4 304 (1.7) EBIT 3,903 3,478 12.2 3,840 1.7 Interest 7 10 (29.3) 23 (68.4) Other Income 404 477 (15.3) 517 (21.8) Exceptional Items - - - - - PBT 4,300 3,945 9.0 4,333 (0.8) Tax 1,481 1,384 7.0 1,401 5.8 PAT 2,819 2,561 10.1 2,933 (3.9) Minority Interest - - - - - Reported PAT 2,819 2,561 10.1 2,933 (3.9) Adjustment - - - - - Adj PAT 2,819 2,561 10.1 2,933 (3.9) Source: Company, In-house research

Decent growth in topline Net sales grew by 7.6% YoY in Q1FY19 led by 14% YoY growth in FMCG (like-to-like basis), 12% YoY in hotels and modest 2.2% (our calculation) in cigarettes. Cigarette volumes surprised positively with growth of 1% YoY (our estimate) after 3 consecutive quarters of steep decline (-6% to -3%). FMCG segment also grew by impressive 14.3% YoY (like-to-like basis) with strong performance across Branded Packaged foods and personal care products. The company improved its market standing across segments driven by new product launches. Hotels segment also posted healthy growth in topline led by higher room rates and strong food and beverage sales. Agribusiness reported 14.2% YoY growth while Paperboards and Packaging segment witnessed muted performance (flat revenue) during the quarter as demand remained weak from end user industries. Recovery in cigarette volumes and better profitability in FMCG segment to aid margin growth EBITDA margin expanded by 161 bps YoY to 39.2% led by improved profitability in cigarettes, FMCG, hotels and paperboard segments. Cigarette business witnessed EBIT margin improvement of 415 bps YoY to 69.4% (our calculation) on the back of volume growth. Despite sustained investments behind brands and gestation cost of new categories, FMCG segment reported 153 bps YoY increase in EBIT margin to 1.7% (our calculation) led by product mix enrichment and cost management initiatives. Hotel segment performance was boosted by higher room rates and operating leverage resulting in EBIT expansion of 213 bps YoY to 3.9%. Paperboard and packaging segment also saw healthy 289 bps YoY expansion in EBIT margin to 21.8% driven by strategic investments in imported pulp substitution, improving pulp yield and higher realization. However, Agribusiness reported tepid performance due to pressure on legal cigarette industry volumes leading to adverse mix and lower export incentives. Further, PAT growth was restricted to 10.1% YoY in Q1FY19 due to lower other income. With recovery in cigarette volumes coupled with better profitability in FMCG segment, we expect EBITDA margin to expand to 38.9%/39.9% in FY19E/20E. EBITDA margin to grew by 167 bps over FY18-20E 25,000 20,000 15,000 10,000 5,000-13,715 14,578 17,201 15,541 38.9% 38.3% 37.5% 36.4% 19,486 39.9% FY16 FY17 FY18 FY19E FY20E EBITDA (Rs. Cr) EBITDA Margin % 41.0% 40.0% 39.0% 38.0% 37.0% 36.0% 35.0% 34.0% Source: Company, In-house research Performance to only get better In Q1FY19 the company reported healthy performance across segments. Going ahead, we expect volume recovery to sustain in cigarettes and strong performance in FMCG segment to continue and as a result, factor revenue CAGR of 8.2%/14.2%, respectively over FY18-20E. This will drive overall revenue CAGR of 9.6% over FY18-20E.

60,000 50,000 40,000 30,000 20,000 10,000 - Revenue to grow at a CAGR of 10% over FY18-20E 48,314 43,738 10.5% 39,642 9.4% 40,255 36,221 8.7% 1.5% 0.4% FY16 FY17 FY18 FY19E FY20E Revenue (Rs. Cr) Growth % 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% Strong growth in profitability going forward 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000-9,328 10,201 25.5% 25.4% 11,223 26.6% 11,908 26.9% 13,449 27.6% FY16 FY17 FY18 FY19E FY20E 28.0% 27.5% 27.0% 26.5% 26.0% 25.5% 25.0% 24.5% 24.0% Net Profit (Rs. Cr) Net Profit Margin % Return ratios trend 50.0 40.0 30.0 20.0 10.0 40.0 25.8 35.7 34.1 34.1 36.0 23.5 22.3 22.4 23.6 0.0 FY16 FY17 FY18 FY19E FY20E RoE (%) RoCE (%) Source: Company, In-house research Key Risks: Adverse cross-currency foreign exchange rate fluctuation. Higher taxation and stringent regulatory norms on cigarette. Slowdown in macro-economic environment would impact hotels business.

Profit & Loss Account (Standalone) Y/E (Rs.Cr) FY17 FY18 FY19E FY20E Total Income operating Cash Flow Statement (Standalone) Y/E (Rs.Cr) FY17 FY18 FY19E FY20E Pre-tax profit 15,503 16,852 18,108 20,451 Depreciation 1,038 1,145 1,273 1,399 Chg in Working Capital 63 1,920 (231) (639) Others (1,389) (1,547) (2,180) (2,364) Tax paid (5,213) (5,720) (6,200) (7,002) Cash flow from operating activities 10,002 12,651 10,770 11,845 Capital expenditure (2,825) (2,826) (3,000) (3,000) Chg in investments (975) (5,036) (1,300) (1,500) Other investing cashflow Cash flow from investing activities 1,019 1,170 2,240 2,424 (2,780) (6,691) (2,060) (2,076) Equity raised/(repaid) 1,067 913 50 - Debt raised/(repaid) (13) (8) - - Dividend paid (8,174) (6,880) (8,389) (9,419) Other financing activities Cash flow from financing activities 40,089 40,628 44,193 48,806 Raw Material cost 15,976 15,790 17,058 18,698 Employee cost 2,444 2,487 2,624 2,851 Other expenses operating 7,090 6,809 7,310 7,772 EBITDA 14,578 15,541 17,201 19,486 Depreciation 1,038 1,145 1,273 1,399 EBIT 13,540 14,396 15,928 18,087 Interest Cost 23 87 60 60 Other income 1,986 2,130 2,240 2,424 Profit before tax 15,503 16,439 18,108 20,451 Tax 5,302 5,628 6,200 7,002 PAT 10,201 10,810 11,908 13,449 Minority Interest - - - - P/L from Associates - - - - Adjusted PAT 10,201 10,810 11,908 13,449 E/o income / (Expense) - 413 - - Reported PAT 10,201 11,223 11,908 13,449 (18) (45) (60) (60) (7,138) (6,020) (8,398) (9,479) Net chg in cash 84 (60) 312 291 Balance Sheet (Standalone) Y/E (Rs.Cr) FY17 FY18 FY19E FY20E Paid up capital 1,215 1,220 1,221 1,221 Reserves and Surplus 44,126 50,180 53,749 57,779 Net worth 45,341 51,400 54,970 59,000 Minority interest - - - - Total Debt 26 18 18 18 Other non-current liabilities 2,027 2,114 2,114 2,114 Total Liabilities 47,394 53,532 57,101 61,132 Total fixed assets 14,926 15,566 17,319 19,120 Capital WIP 3,491 5,026 5,000 4,800 Goodwill - - - - Investments 18,585 23,397 24,697 26,197 Net Current assets 7,615 5,750 6,292 7,222 Other non-current assets 2,776 3,793 3,793 3,793 Total Assets 47,394 53,532 57,101 61,132 Key Ratios (Standalone) Y/E FY17 FY18 FY19E FY20E Growth (%) Net Sales 9.4 1.5 8.7 10.5 EBITDA 6.3 6.6 10.7 13.3 Net profit 9.4 6.0 10.2 12.9 Margin (%) EBITDA 36.4 38.3 38.9 39.9 EBIT 33.8 35.4 36.0 37.1 NPM 25.4 26.6 26.9 27.6 Return Ratios (%) RoE 23.5 22.3 22.4 23.6 RoCE 35.7 34.1 34.1 36.0 Per share data (Rs.) EPS 8.4 8.9 9.8 11.0 DPS 4.7 5.1 5.7 6.4 Valuation(x) P/E 36.2 34.3 31.1 27.6 EV/EBITDA 25.1 23.7 21.4 18.9 EV/Net Sales 9.2 9.1 8.4 7.6 P/B 8.1 7.2 6.7 6.3 Turnover Ratios (x) Net Sales/GFA 2.5 2.3 2.2 2.1 Sales/Total Assets 0.8 0.7 0.7 0.7

Rating Criteria Large Cap. Return Mid/Small Cap. Return Buy More than equal to 10% Buy More than equal to 15% Hold Between 10% & -5% Accumulate* Upside between 10% & 15% Reduce Less than -5% Hold Between 0% & 10% * To satisfy regulatory requirements, we attribute Accumulate as Buy and Reduce as Sell. * ITC is a large-cap company. Disclaimer: Reduce/sell Less than 0% The SEBI registration number is INH200000394. The analyst for this report certifies that all the views expressed in this report accurately reflect his / her personal views about the subject company or companies, and its / their securities. No part of his / her compensation was / is / will be, directly / indirectly related to specific recommendations or views expressed in this report. This material is for the personal information of the authorized recipient, and no action is solicited on the basis of this. It is not to be construed as an offer to sell, or the solicitation of an offer to buy any security, in any jurisdiction, where such an offer or solicitation would be illegal. We have reviewed the report, and in so far as it includes current or historical information, it is believed to be reliable, though its accuracy or completeness cannot be guaranteed. Neither Wealth India Financial Services Pvt. Ltd., nor any person connected with it, accepts any liability arising from the use of this document. The recipients of this material should rely on their own investigations and take their own professional advice. Price and value of the investments referred to in this material may go up or down. Past performance is not a guide for future performance. We and our affiliates, officers, directors, and employees worldwide: 1. Do not have any financial interest in the subject company / companies in this report; 2. Do not have any actual / beneficial ownership of one per cent or more in the company / companies mentioned in this document, or in its securities at the end of the month immediately preceding the date of publication of the research report, or the date of public appearance; 3. Do not have any other material conflict of interest at the time of publication of the research report, or at the time of public appearance; 4. Have not received any compensation from the subject company / companies in the past 12 months; 5. Have not managed or co-managed the public offering of securities for the subject company / companies in the past 12 months; 6. Have not received any compensation for investment banking, or merchant banking, or brokerage services from the subject company / companies in the past 12 months; 7. Have not served as an officer, director, or employee of the subject company; 8. Have not been engaged in market making activity for the subject company; This document is not for public distribution. It has been furnished to you solely for your information, and must not be reproduced or redistributed to any other person. Contact Us: Funds India Uttam Building, Third Floor No. 38 & 39 Whites Road Royapettah Chennai 600014 T: +91 7667 166 166 Email: contact@fundsindia.com

Dion s Disclosure and Disclaimer I, Abhijit Kumar Das, employee of Dion Global Solutions Limited (Dion) is engaged in preparation of this report and hereby certify that all the views expressed in this research report (report) reflect my personal views about any or all of the subject issuer or securities. Disclaimer This report has been prepared by Dion and the report & its contents are the exclusive property of the Dion and the client cannot tamper with the report or its contents in any manner and the said report, shall in no case, be further distributed to any third party for commercial use, with or without consideration. Recipient shall not further distribute the report to a third party for a commercial consideration as this report is being furnished to the recipient solely for the purpose of information. Dion has taken steps to ensure that facts in this report are based on reliable information but cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this report. It is hereby confirmed that wherever Dion has employed a rating system in this report, the rating system has been clearly defined including the time horizon and benchmarks on which the rating is based. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this report is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. Dion has not taken any steps to ensure that the securities referred to in this report are suitable for any particular investor. This report is not to be relied upon in substitution for the exercise of independent judgment. Opinions or estimates expressed are current opinions as of the original publication date appearing on this report and the information, including the opinions and estimates contained herein, are subject to change without notice. Dion is under no duty to update this report from time to time. Dion or its associates including employees engaged in preparation of this report and its directors do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of securities, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. The investments or services contained or referred to in this report may not be suitable for all equally and it is recommended that an independent investment advisor be consulted. In addition, nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to individual circumstances or otherwise constitutes a personal recommendation of Dion. REGULATORY DISCLOSURES: Dion is engaged in the business of developing software solutions for the global financial services industry across the entire transaction lifecycle and inter-alia provides research and information services essential for business intelligence to global companies and financial institutions. Dion is listed on BSE Limited (BSE) and is also registered under the SEBI (Research Analyst) Regulations, 2014 (SEBI Regulations) as a Research Analyst vide Registration No. INH100002771. Dion s activities were neither suspended nor has it defaulted with requirements under the Listing Agreement and / or SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with the BSE in the last five years. Dion has not been debarred from doing business by BSE / SEBI or any other authority.

In the context of the SEBI Regulations, we affirm that we are a SEBI registered Research Analyst and in the course of our business, we issue research reports /research analysis etc that are prepared by our Research Analysts. We also affirm and undertake that no disciplinary action has been taken against us or our Analysts in connection with our business activities. In compliance with the above mentioned SEBI Regulations, the following additional disclosures are also provided which may be considered by the reader before making an investment decision: 1. Disclosures regarding Ownership Dion confirms that: (i) Dion/its associates have no financial interest or any other material conflict in relation to the subject company (ies) covered herein at the time of publication of this report. (ii) It/its associates have no actual / beneficial ownership of 1% or more securities of the subject company (ies) covered herein at the end of the month immediately preceding the date of publication of this report. Further, the Research Analyst confirms that: (i) He, his associates and his relatives have no financial interest in the subject company (ies) covered herein, and they have no other material conflict in the subject company at the time of publication of this report. (ii) he, his associates and his relatives have no actual/beneficial ownership of 1% or more securities of the subject company (ies) covered herein at the end of the month immediately preceding the date of publication of this report. 2. Disclosures regarding Compensation: During the past 12 months, Dion or its Associates: (a) Have not managed or co-managed public offering of securities for the subject company (b) Have not received any compensation for investment banking or merchant banking or brokerage services from the subject company (c) Have not received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject (d) Have not received any compensation or other benefits from the subject company or third party in connection with this report 3. Disclosure regarding the Research Analyst s connection with the subject company: It is affirmed that I, Abhijit Kumar Das employed as Research Analyst by Dion and engaged in the preparation of this report have not served as an officer, director or employee of the subject company 4. Disclosure regarding Market Making activity: Neither Dion /its Research Analysts have engaged in market making activities for the subject company. Copyright in this report vests exclusively with Dion.